11.07.2015 Views

Hematologic Disorders - Department of Surgery at SUNY Downstate ...

Hematologic Disorders - Department of Surgery at SUNY Downstate ...

Hematologic Disorders - Department of Surgery at SUNY Downstate ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

www.downst<strong>at</strong>esurgery.org<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>Sophia L Fu, MD<strong>SUNY</strong> Downst<strong>at</strong>e Medical Center,Brooklyn, NYChief Resident Grand RoundsMarch 29, 2012


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgOverview‣ Splenic‣ Peripheral Blood‣ Bone marrow‣ Genetic Disorder‣ Myeloprolifer<strong>at</strong>ive


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgGoals <strong>of</strong> Splenectomy‣ Amelior<strong>at</strong>e the p<strong>at</strong>hologic effects <strong>of</strong> splenicsequestr<strong>at</strong>ion and symptom<strong>at</strong>ic splenomegaly‣ Correct the hem<strong>at</strong>ologic abnormality‣ Aid in diagnosis and staging‣ Rare


www.downst<strong>at</strong>esurgery.orgAutoimmune/Idiop<strong>at</strong>hic<strong>Disorders</strong>


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgWh<strong>at</strong> is the most commonindic<strong>at</strong>ion for splenectomy in theUS?‣ A) Felty Syndrome‣ B) Thrombotic Thrombocytopenic Purpura‣ C) Autoimmune Hemolytic Anemia‣ D) Idiop<strong>at</strong>hic Thrombocytopenic Purpura‣ E) Sarcoidosis


www.downst<strong>at</strong>esurgery.orgIdiop<strong>at</strong>hicThrombocytopenicPurpura


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgA 43-year-old man has thrombocytopenia, ecchymoses, and ahistory <strong>of</strong> melena. His primary doctor suspects th<strong>at</strong> he might haveidiop<strong>at</strong>hic thrombocytopenia purpura (ITP). Which <strong>of</strong> thefollowing is true about this condition?‣ A It is characterized by a low pl<strong>at</strong>elet count, mucosal hemorrhage, normal bonemarrow, and an enlarged spleen.‣ B It is caused by splenic overproduction <strong>of</strong> IgM, which <strong>at</strong>tacks the pl<strong>at</strong>eletmembrane and causes pl<strong>at</strong>elet destruction.‣ C The bone marrow <strong>of</strong>ten hypertrophies to counteract the increased pl<strong>at</strong>eletdestruction.‣ D It affects young men more commonly than women.‣ E Diagnosis requires exclusion <strong>of</strong> other causes <strong>of</strong> thrombocytopenia.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgThe p<strong>at</strong>ient previously described undergoes a complete workupand ITP is diagnosed. Which <strong>of</strong> the following about thetre<strong>at</strong>ment <strong>of</strong> ITP is true?‣ A Pl<strong>at</strong>elet transfusions are best given before lig<strong>at</strong>ion <strong>of</strong> the splenic artery.‣ B Initial medical therapy includes steroid therapy with the possible addition <strong>of</strong>intravenous IgG.‣ C Initial response r<strong>at</strong>es to medical therapy in adults are as high as 75%, withpermanent cure from medical therapy being achieved in gre<strong>at</strong>er than 50%.‣ D Spontaneous resolution is rare in children.‣ E Splenectomy is indic<strong>at</strong>ed if ITP does not improve after 1 year <strong>of</strong> steroidtherapy or if thrombocytopenia recurs following steroid taper.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgMechanism <strong>of</strong> ITP


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgClinical Present<strong>at</strong>ion <strong>of</strong> ITP


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.org‣ Spleen is <strong>of</strong> normal size‣ MegakaryocytesDiagnosis <strong>of</strong> ExclusionIllnesses‣ HIV‣ SLE‣ Antiphospholipid Ab Syndrome‣ Hep<strong>at</strong>itis C‣ Lymphoprolifer<strong>at</strong>ive <strong>Disorders</strong>Medic<strong>at</strong>ion‣ Cocaine & gold‣ Antibiotics &antiinflamm<strong>at</strong>ories‣ Heparin, quinidine,abciximab


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgITP in Children‣ Young age (70% will resolve‣ Intracranial hemorrhage‣ Plt


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgManagement <strong>of</strong> ITP in Children‣ Medical‣ Observ<strong>at</strong>ion‣ IV IG‣ Prednisone‣4 mg/kg x 4 days‣ Splenectomy‣ Thrombocytopenia‣>1 year‣ Failures <strong>of</strong> medical therapy‣ Severe thrombocytopenia‣ Severe or life-thre<strong>at</strong>eningbleeding‣Rare!


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgITP in Adults‣ Insidious onset‣ Tre<strong>at</strong>ment begins:‣ Plt 20,000 – 30,000/mm3‣ 50,000/mm3 w/significant mucosal bleeding


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgMedical Management <strong>of</strong> ITP inAdults‣ Steroid‣ 1 to 1.5 mg/kg/day‣3 qwwka‣ Taper when response‣ 50-75% response r<strong>at</strong>e‣ 15-20% long-termresponse‣ IV IG‣ Internal bleeding w/plt


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgSplenectomy in ITP in Adults‣ Plt counts remain low after 6-8 wks <strong>of</strong> steroid therapy‣ Failure <strong>of</strong> medical therapy‣ Relapse‣ Unwanted side effects from prolonged steroid use‣ 75-85% permanent response‣ Pl<strong>at</strong>elet transfusion‣ Peri-op bleeding‣ Plts


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgA 43-year-old man has thrombocytopenia, ecchymoses, and ahistory <strong>of</strong> melena. His primary doctor suspects th<strong>at</strong> he might haveidiop<strong>at</strong>hic thrombocytopenia purpura (ITP). Which <strong>of</strong> thefollowing is true about this condition?‣ A It is characterized by a low pl<strong>at</strong>elet count, mucosal hemorrhage, normal bonemarrow, and an enlarged spleen.‣ B It is caused by splenic overproduction <strong>of</strong> IgM, which <strong>at</strong>tacks the pl<strong>at</strong>eletmembrane and causes pl<strong>at</strong>elet destruction.‣ C The bone marrow <strong>of</strong>ten hypertrophies to counteract the increased pl<strong>at</strong>eletdestruction.‣ D It affects young men more commonly than women.‣ E Diagnosis requires exclusion <strong>of</strong> other causes <strong>of</strong> thrombocytopenia.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgIdiop<strong>at</strong>hic thrombocytopenia purpura is a disorder <strong>of</strong>increased pl<strong>at</strong>elet destruction caused by autoantibodies to pl<strong>at</strong>eletmembrane components. This results in pl<strong>at</strong>elet phagocytosis in thespleen, and the bone marrow does not adequ<strong>at</strong>ely compens<strong>at</strong>e forthis increased destruction. Although ITP is characterized by a lowpl<strong>at</strong>elet count, mucosal hemorrhage, and rel<strong>at</strong>ively normal bonemarrow (not hyperactive), the spleen is not enlarged. Theautoantibodies are IgG antibodies, not IgM, directed against thepl<strong>at</strong>elet fibrinogen receptor. The mechanism underlying the use <strong>of</strong>intravenous IgG for the tre<strong>at</strong>ment <strong>of</strong> ITP is th<strong>at</strong> IgG s<strong>at</strong>ur<strong>at</strong>es thefibrinogen receptors so th<strong>at</strong> they will not bind and thus destroypl<strong>at</strong>elets. This autoimmune disorder affects women morecommonly than men. A diagnosis <strong>of</strong> ITP requires exclusion <strong>of</strong> otherpotential causes <strong>of</strong> thrombocytopenia such as drugs,myelodysplasia, thrombotic thrombocytopenia purpura (TTP),systemic lupus erythem<strong>at</strong>osus, lymphoma, and chronicdissemin<strong>at</strong>ed intravascular coagul<strong>at</strong>ion.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgThe p<strong>at</strong>ient previously described undergoes a complete workupand ITP is diagnosed. Which <strong>of</strong> the following about thetre<strong>at</strong>ment <strong>of</strong> ITP is true?‣ A Pl<strong>at</strong>elet transfusions are best given before lig<strong>at</strong>ion <strong>of</strong> the splenic artery.‣ B Initial medical therapy includes steroid therapy with the possible addition <strong>of</strong>intravenous IgG.‣ C Initial response r<strong>at</strong>es to medical therapy in adults are as high as 75%, withpermanent cure from medical therapy being achieved in gre<strong>at</strong>er than 50%.‣ D Spontaneous resolution is rare in children.‣ E Splenectomy is indic<strong>at</strong>ed if ITP does not improve after 1 year <strong>of</strong> steroidtherapy or if thrombocytopenia recurs following steroid taper.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgInitial therapy for idiop<strong>at</strong>hic thrombocytopenia purpura is medical and consists <strong>of</strong>high-dose corticosteroids, usually prednisone, 1 mg/kg/day. The goal <strong>of</strong> therapy is toinduce remission and achieve pl<strong>at</strong>elet counts higher than 100,000/mm 3 . This is effectiveinitially in approxim<strong>at</strong>ely 75% <strong>of</strong> p<strong>at</strong>ients, usually within 1 week, but up to 3 weeks <strong>of</strong>therapy may be required. Tre<strong>at</strong>ment is generally initi<strong>at</strong>ed when pl<strong>at</strong>elet counts fall to lessthan 20,000 to 30,000/mm 3 or for individuals with pl<strong>at</strong>elet counts <strong>of</strong> less than50,000/mm 3 and mucous membrane bleeding or significant risk factors for bleeding.Although the initial response to tre<strong>at</strong>ment is good, only 15% to 25% <strong>of</strong> p<strong>at</strong>ients achievea lasting response. If pl<strong>at</strong>elet counts remain low despite steroid therapy, intravenous IgGis indic<strong>at</strong>ed <strong>at</strong> doses <strong>of</strong> 1 g/kg for 2 days. In most cases, this increases pl<strong>at</strong>elet countswithin 3 days. In contrast to adults, 70% to 80% <strong>of</strong> children will experience spontaneouspermanent remission. Splenectomy is considered if pl<strong>at</strong>elet counts remain below10,000/mm 3 after 8 weeks <strong>of</strong> therapy, regardless <strong>of</strong> whether bleeding is present.Splenectomy is also recommended for those who experience a relapse after initialsuccess with glucocorticoid tre<strong>at</strong>ment or who have significant morbidity from continuedhigh-dose steroids. Intracranial bleeding in p<strong>at</strong>ients with ITP is usually managed byprompt administr<strong>at</strong>ion <strong>of</strong> intravenous IgG followed by splenectomy. Finally, women intheir second trimester <strong>of</strong> pregnancy are <strong>of</strong>fered splenectomy if they have pl<strong>at</strong>elet counts<strong>of</strong> less than 10,000/mm 3 or bleeding with counts <strong>of</strong> less than 30,000/mm 3 despiteappropri<strong>at</strong>e medical therapy. Pl<strong>at</strong>elet transfusion during splenectomy should be withhelduntil after lig<strong>at</strong>ion <strong>of</strong> the splenic artery, if possible, to prevent pl<strong>at</strong>elet consumption.


www.downst<strong>at</strong>esurgery.org


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgWh<strong>at</strong> is the likely diagnosis <strong>of</strong> a 17yo female w/fever, purpura,hemolytic anemia, and hem<strong>at</strong>uriaw/renal insufficiency?‣ A) Viral illness‣ B) Thrombotic Thrombocytopenic Purpura‣ C) Autoimmune Hemolytic Anemia‣ D) Idiop<strong>at</strong>hic Thrombocytopenic Purpura‣ E) Henoch Schonlein Purpura


www.downst<strong>at</strong>esurgery.orgThromboticThrombocytopenicPurpura


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>A 17-year-old girl is evalu<strong>at</strong>ed for fever, purpura, hemolyticanemia, and hem<strong>at</strong>uria with renal insufficiency. Focal neurologicdefects soon develop, and head computed tomography (CT)demonstr<strong>at</strong>es an intracranial hemorrhage. Which <strong>of</strong> the following istrue regarding this condition?‣ A Splenectomy is cur<strong>at</strong>ive in most p<strong>at</strong>ients and should be considered after a trial <strong>of</strong>steroids.‣ B It is caused by hyaline membranes th<strong>at</strong> form within arterioles and capillaries andresultant pl<strong>at</strong>elet aggreg<strong>at</strong>ion.‣ C Plasmapheresis is considered as a last resort when other therapy fails.‣ D Administr<strong>at</strong>ion <strong>of</strong> pl<strong>at</strong>elets can result in clinical improvement, thereby allowingsplenectomy to be delayed.www.downst<strong>at</strong>esurgery.org‣ E Even with rapid progression, the prognosis is generally good because <strong>of</strong> the highsuccess <strong>of</strong> medical therapy with splenectomy for salvage.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgMechanism <strong>of</strong> TTPMoake JL. Semin in Hem<strong>at</strong>ol. 2004


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgClinical Present<strong>at</strong>ion <strong>of</strong> TTP‣ Damage to the endothelium triggers pl<strong>at</strong>elet deposition in small arterioles andcapillaries‣ Microvascular thrombotic episodes


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>‣ PetetchiaeSymptom<strong>at</strong>ology <strong>of</strong> TTP‣ lower extremititeswww.downst<strong>at</strong>esurgery.org‣ Fever, myalgia, & f<strong>at</strong>igue‣ Neurological Symptoms‣ Headache, mental st<strong>at</strong>us changes, seizures, coma‣ CHF or cardiac arrhythmias‣ Renal failure


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgDiagnosis & Etiology <strong>of</strong> TTP‣ Peripheral Blood Smear‣ Schistocytes‣ Nucleophilic red blood cells‣ Basophilic stipplingIllnesses‣ Pregnancy‣ PostpartumMedic<strong>at</strong>ion‣ Ticlopidine‣ Clopidogrel


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgManagement <strong>of</strong> TTP‣ Medical‣ Daily plasmapharesis‣ Daily FFP‣ Splenectomy‣ Frequent relapses‣ Prolongs relapse-freeinterval when in combow/high-dose steroidtherapy‣ Response r<strong>at</strong>e: 40%


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>A 17-year-old girl is evalu<strong>at</strong>ed for fever, purpura, hemolyticanemia, and hem<strong>at</strong>uria with renal insufficiency. Focal neurologicdefects soon develop, and head computed tomography (CT)demonstr<strong>at</strong>es an intracranial hemorrhage. Which <strong>of</strong> the following istrue regarding this condition?‣ A Splenectomy is cur<strong>at</strong>ive in most p<strong>at</strong>ients and should be considered after a trial <strong>of</strong>steroids.‣ B It is caused by hyaline membranes th<strong>at</strong> form within arterioles and capillaries andresultant pl<strong>at</strong>elet aggreg<strong>at</strong>ion.‣ C Plasmapheresis is considered as a last resort when other therapy fails.‣ D Administr<strong>at</strong>ion <strong>of</strong> pl<strong>at</strong>elets can result in clinical improvement, thereby allowingsplenectomy to be delayed.www.downst<strong>at</strong>esurgery.org‣ E Even with rapid progression, the prognosis is generally good because <strong>of</strong> the highsuccess <strong>of</strong> medical therapy with splenectomy for salvage.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgThis p<strong>at</strong>ient has thrombotic thrombocytopenic purpura. Thedisease is characterized by occlusion <strong>of</strong> arterioles and capillariesby hyaline deposits <strong>of</strong> aggreg<strong>at</strong>ed pl<strong>at</strong>elets and fibrin. First-linetherapy is plasmapheresis. Fresh frozen plasma and high-dosecorticosteroids may be used to control bleeding. Splenectomy isnot cur<strong>at</strong>ive and is considered only for salvage therapy. Mortalityr<strong>at</strong>es in p<strong>at</strong>ients with TTP can approach 50%, mostly fromintracranial hemorrhage or renal failure. The disease can have arapidly fulminant course. Most long-term survivors <strong>of</strong> TTP haveundergone splenectomy. Pl<strong>at</strong>elet transfusion does not control thebleeding; therapy should be focused on high-volumeplasmapheresis.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgSummary <strong>of</strong> TTP


www.downst<strong>at</strong>esurgery.org


www.downst<strong>at</strong>esurgery.orgAutoimmuneHemolytic Anemia(AIHA)


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgPresent<strong>at</strong>ion <strong>of</strong> AIHA‣ Autoantibodies are formed & directed against red blood cell antigens‣ Signs & Symptoms <strong>of</strong> anemia‣ Physiology <strong>of</strong> red blood cells‣ Sequestered by macrophages‣ Destroyed in periphery‣ Etiology‣ Idiop<strong>at</strong>hic‣ Infectious‣ SLE‣ Leukemia


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgTypes <strong>of</strong> AIHA‣ Warm AutoimmuneHemolytic Anemia‣ Cold autoantibodysyndromes‣ Cold agglutininsyndrome


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>Warm AIHA‣ IgG autoantibodies react optimally <strong>at</strong> 37°C‣ Peak incidence <strong>at</strong> 40-70 yo‣ Children‣ Self-limited: 2-3 mo‣ S/p viral illnesswww.downst<strong>at</strong>esurgery.org‣ Diagnosis on clinical findings‣ + peripheral blood smear‣ Direct antiglobulin test


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgManagement <strong>of</strong> Warm AIHA‣ Medical‣ High-dose steroids‣ Taper to lowest dose tocontrol hemolysis‣ Children respond betterthan adults‣ Splenectomy‣ Failed remission in 3 wks‣ Hb can’t be maintained bylow dose steroids‣ Response r<strong>at</strong>e: 60-80% w/i2 wks <strong>of</strong> splenectomy‣ 50% will require low-dosesteroids (15mg/day)


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgCold Agglutinin Syndrome‣ IgM autoantibodies react optimally <strong>at</strong> 0-5°C‣ 15-20% <strong>of</strong> AIHA‣ Etiology‣ Infectious process: EBV‣ Lymphoprolifer<strong>at</strong>ive disorder‣ Raynaud phenomenon


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgManagement <strong>of</strong> Cold agglutinin‣ Medical‣ Avoid cold‣Stay indoors‣Wear warm clothing‣ Alkyl<strong>at</strong>ing agents‣ Splenectomy‣ Not indic<strong>at</strong>ed!!!‣ Erythrocytes are destroyedin the liver & not spleen‣Chlorambucil‣Cyclophosphamide‣ Plasmapharesis


www.downst<strong>at</strong>esurgery.orgSarcoidosis


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgA 56-year-old African-American man with a history <strong>of</strong> lung disease isreferred to your <strong>of</strong>fice for evalu<strong>at</strong>ion <strong>of</strong> an abnormality seen in his spleen onabdominal CT. He also has a history <strong>of</strong> sarcoidosis. Which <strong>of</strong> the following isnot true about splenic involvement in his case?‣ A One fourth <strong>of</strong> p<strong>at</strong>ients have splenomegaly from granulom<strong>at</strong>ous involvement <strong>of</strong> thespleen.‣ B Not all p<strong>at</strong>ients who have splenomegaly experience thrombocytopenia.‣ C Splenic rupture can occur as a result <strong>of</strong> granulom<strong>at</strong>ous involvement <strong>of</strong> the spleen.‣ D Case<strong>at</strong>ing granulomas are the hallmark <strong>of</strong> sarcoidosis.‣ E P<strong>at</strong>ients with active sarcoidosis may have elev<strong>at</strong>ed levels <strong>of</strong> angiotensin-convertingenzyme, which may be secreted by cells within the granuloma.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgSplenic Sarcoidosis‣ Non-case<strong>at</strong>ing granulom<strong>at</strong>ous disease‣ 90% have primary lung involvement‣ Splenic involvement usually part <strong>of</strong> multi-organ sarcoidosis‣ Splenomegaly: 40%‣ Massive splenomegaly: 3%‣ Tre<strong>at</strong>ment:‣ Corticosteroids or methotrex<strong>at</strong>e‣ Splenectomy‣ Splenomegaly, intractable pain, hem<strong>at</strong>ologic sequestr<strong>at</strong>ion


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgA 56-year-old African-American man with a history <strong>of</strong> lung disease isreferred to your <strong>of</strong>fice for evalu<strong>at</strong>ion <strong>of</strong> an abnormality seen in his spleen onabdominal CT. He also has a history <strong>of</strong> sarcoidosis. Which <strong>of</strong> the following isnot true about splenic involvement in his case?‣ A One fourth <strong>of</strong> p<strong>at</strong>ients have splenomegaly from granulom<strong>at</strong>ous involvement <strong>of</strong> thespleen.‣ B Not all p<strong>at</strong>ients who have splenomegaly experience thrombocytopenia.‣ C Splenic rupture can occur as a result <strong>of</strong> granulom<strong>at</strong>ous involvement <strong>of</strong> the spleen.‣ D Case<strong>at</strong>ing granulomas are the hallmark <strong>of</strong> sarcoidosis.‣ E P<strong>at</strong>ients with active sarcoidosis may have elev<strong>at</strong>ed levels <strong>of</strong> angiotensin-convertingenzyme, which may be secreted by cells within the granuloma.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgSarcoidosis is a disease th<strong>at</strong> is characterized by noncase<strong>at</strong>inggranulomas. One quarter <strong>of</strong> p<strong>at</strong>ients will have granulom<strong>at</strong>ousinvolvement <strong>of</strong> the spleen, although bil<strong>at</strong>eral lung involvement iseven more common. Granulomas may also be found in the liver.Splenic involvement can lead to splenomegaly, but <strong>of</strong> thoseaffected, only 20% have hypersplenism (increased hemolyticfunction <strong>of</strong> the spleen resulting in a deficiency <strong>of</strong> one or moreperipheral blood elements, hypercellularity <strong>of</strong> the bone marrow,and splenomegaly). Thrombocytopenia usually resolves followingsplenectomy. Complic<strong>at</strong>ions <strong>of</strong> granulom<strong>at</strong>ous involvement <strong>of</strong> thespleen include splenic rupture, anemia, and neutropenia.Epithelial cells within the sarcoid granulomas may produceangiotensin-converting enzyme, thereby resulting in elev<strong>at</strong>edserum levels <strong>of</strong> this enzyme.


www.downst<strong>at</strong>esurgery.orgFelty’s Syndrome


www.downst<strong>at</strong>esurgery.orgA 49-year-old woman with Felty's syndromeundergoes successful splenectomy. Several years aftersurgery, examin<strong>at</strong>ion <strong>of</strong> her peripheral blood smearwould reveal which one <strong>of</strong> the following to be true?<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>‣ A Howell-Jolly bodies, which are suggestive <strong>of</strong> the presence <strong>of</strong> an accessoryspleen‣ B Stippling, spur cells, and target cells because <strong>of</strong> the lack <strong>of</strong> filtr<strong>at</strong>ion‣ C High levels <strong>of</strong> properdin and tuftsin‣ D No change in the level <strong>of</strong> antibodies needed to clear organisms as in thepresplenectomy st<strong>at</strong>e‣ E Red blood cells undergoing m<strong>at</strong>ur<strong>at</strong>ion more quickly.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgFelty’s Syndrome‣ Rheum<strong>at</strong>oid arthritis‣ Unexplained neutropenia‣ Splenomegaly‣ HLA DR4 antigen: 85%‣ Tre<strong>at</strong>ment‣ Low-dose methotrex<strong>at</strong>e‣ Disease-modifying antirheum<strong>at</strong>ic drugs‣ Splenectomy‣ Medical tre<strong>at</strong>ment failure w/recurrent infections or severe neutropenia


www.downst<strong>at</strong>esurgery.orgA 49-year-old woman with Felty's syndromeundergoes successful splenectomy. Several years aftersurgery, examin<strong>at</strong>ion <strong>of</strong> her peripheral blood smearwould reveal which one <strong>of</strong> the following to be true?<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>‣ A Howell-Jolly bodies, which are suggestive <strong>of</strong> the presence <strong>of</strong> an accessoryspleen‣ B Stippling, spur cells, and target cells because <strong>of</strong> the lack <strong>of</strong> filtr<strong>at</strong>ion‣ C High levels <strong>of</strong> properdin and tuftsin‣ D No change in the level <strong>of</strong> antibodies needed to clear organisms as in thepresplenectomy st<strong>at</strong>e‣ E Red blood cells undergoing m<strong>at</strong>ur<strong>at</strong>ion more quickly.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgHowell-Jolly bodies are abnormal cytoplasmic inclusions within red blood cells.They are seen in individuals who have undergone splenectomy because normally theyare removed by a functioning spleen, and thus their absence would suggest the presence<strong>of</strong> an accessory spleen. Stippling, spur cells, and target cells are all functionally alterederythrocytes th<strong>at</strong> are normally cleared from the circul<strong>at</strong>ion by the spleen and thus arecommonly seen following splenectomy. Properdin and tuftsin are important opsoninsmanufactured in the spleen. Properdin helps initi<strong>at</strong>e the altern<strong>at</strong>ive p<strong>at</strong>hway <strong>of</strong>complement activ<strong>at</strong>ion, which is particularly useful for fighting encapsul<strong>at</strong>edorganisms. Tuftsin enhances the phagocytic activity <strong>of</strong> granulocytes. Asplenicindividuals lack the ability to produce these substances. The spleen is the initial site <strong>of</strong>IgM synthesis in response to bacteria. Without this primary defense mechanism,asplenic individuals require increased levels <strong>of</strong> antibodies to clear organisms rel<strong>at</strong>ive tothe presplenectomy st<strong>at</strong>e. Erythrocytes do not undergo m<strong>at</strong>ur<strong>at</strong>ion more quickly aftersplenectomy. As part <strong>of</strong> its “pitting” function, the spleen removes cytoplasmicinclusions (particles such as nuclear remnants [Howell-Jolly bodies], insoluble globinprecipit<strong>at</strong>es [Heinz bodies], and endocytic vacuoles) from within circul<strong>at</strong>ing red bloodcells. Felty's syndrome is an uncommon disorder marked by splenomegaly,neutropenia, and rheum<strong>at</strong>oid arthritis. P<strong>at</strong>ients may have thrombocytopenia and anemia,with a predisposition to infections. Splenectomy in p<strong>at</strong>ients with Felty syndrome isbeneficial in correcting the anemia and neutropenia associ<strong>at</strong>ed with this syndrome.


www.downst<strong>at</strong>esurgery.orgRed Blood Cell<strong>Disorders</strong>


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgWh<strong>at</strong> is the most common redblood cell disorder in Europe andNorth America?‣ A) Hereditary Elliptocytosis‣ B) Hereditary Pyropoikilocytosis‣ C) Hereditary Spherocytosis‣ D) Hereditary Stom<strong>at</strong>ocytosis‣ E) Hereditary Xerocytosis‣ F) Wh<strong>at</strong>’s a Red Blood Cell Disorder?


www.downst<strong>at</strong>esurgery.orgHereditarySpherocytosis (HS)


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgA 10-year-old boy is found to have an abnormal complete blood countnotable for an elev<strong>at</strong>ed mean cell hemoglobin concentr<strong>at</strong>ion, an elev<strong>at</strong>ed redcell distribution width, and reticulocytosis. On examin<strong>at</strong>ion <strong>of</strong> his peripheralsmear, the red blood cells exhibit a lack <strong>of</strong> central pallor and loss <strong>of</strong> the usualbiconcave shape, and the cells are fairly uniform in size and shape. Which <strong>of</strong>the following is true regarding this condition?‣ A It is usually transmitted as an autosomal recessive disorder and causes a membraneabnormality th<strong>at</strong> results in decreased osmotic fragility.‣ B Splenectomy can decrease the incidence <strong>of</strong> secondary complic<strong>at</strong>ions such as jaundice,pigmented gallstones, and anemia.‣ C <strong>Surgery</strong> should be delayed until after the age <strong>of</strong> 10 because <strong>of</strong> the risk foroverwhelming post-splenectomy sepsis in younger p<strong>at</strong>ients.‣ D It is less severe than other heredity membrane disorders, including pyruv<strong>at</strong>e kinasedeficiency, sickle cell anemia, thalassemia, and elliptocytosis, and less likely to requiresplenectomy than these conditions.‣ E It is associ<strong>at</strong>ed with a small spleen.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgPartial vs total splenectomy in children withhereditary spherocytosis…‣ A is associ<strong>at</strong>ed with persistent anemia‣ B is associ<strong>at</strong>ed with a higher future risk <strong>of</strong> cholelithiasis‣ C is associ<strong>at</strong>ed with splenic regrowth th<strong>at</strong> predicts failure‣ D is associ<strong>at</strong>ed with a shorter postoper<strong>at</strong>ive length <strong>of</strong> stay‣ E will l<strong>at</strong>er require completion splenectomy


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgPhysiology <strong>of</strong> HS‣ Deficiency <strong>of</strong> cytoskeletal protein spectrin & ankyrin‣ Loss <strong>of</strong> cell membrane surface area‣ Sphering <strong>of</strong> RBCs‣ Increased osmotic fragility & decreased deformability‣ Impairs passage <strong>of</strong> RBC through splenic pulp‣ Prem<strong>at</strong>ure destruction <strong>of</strong> spherocytes‣ Autosomal Dominant‣ 75% will have family member‣ Autosomal recessive variant (rare)‣ More severe hemolytic anemia


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>‣ Mild cases:Present<strong>at</strong>ion <strong>of</strong> HS‣ Asymptom<strong>at</strong>ic or mild jaundice‣ Severe cases:www.downst<strong>at</strong>esurgery.org‣ Anemia‣ Jaundice‣ Splenomegaly‣ Cholelithiasis w/pigmented stones‣ 50% & after age 5 years‣ Diagnosis by family Hx, blood smear & splenomegaly‣ Spherocytes & reticulocytosis


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.org‣ Splenectomy is cur<strong>at</strong>ive!!!Tre<strong>at</strong>ment <strong>of</strong> HS‣ Indic<strong>at</strong>ed in common forms <strong>of</strong> HS‣ Delay until age 5 to prevent OPSI‣ Cholecystecomy concomittant if gallstones arepresent‣ Milder forms‣ Controversial‣ Partial splenectomy in children younger than 5 yo


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgOther Cell Membrane <strong>Disorders</strong>‣ Hereditary Elliptocytosis‣ Mut<strong>at</strong>ion <strong>of</strong> RBC cellmembrane skeletonproteins‣ AD‣ Chronic hemolysis:‣Blood transfusion‣ Severe hemolysis:‣Splenectomy is cur<strong>at</strong>ive‣ Hereditary Poikilocytosis‣ Thermal instability <strong>of</strong> RBC‣ Micropoikilocytosis‣ Subtype <strong>of</strong> common HE‣ AR‣ Newborns & infants presentw/anemia & jaundice‣ Severe anemia:‣Splenectomy is cur<strong>at</strong>ive


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgMore Cell Membrane <strong>Disorders</strong>‣ Hereditary Stom<strong>at</strong>ocytosis‣ Hereditary Xerocytosis‣ Mouth-shaped area <strong>of</strong> centralpallor‣ AD‣ Severe hemolysis:‣Splenectomy should becarefully considered‣May develop hypercoagulabilityw/c<strong>at</strong>astrophic thromboticepisodes‣ Target cells‣ Membrane c<strong>at</strong>ionpermeability & cell volumedecreased‣ AD‣ Severe hemolysis:‣Splenectomy improvesanemia


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgA 10-year-old boy is found to have an abnormal complete blood countnotable for an elev<strong>at</strong>ed mean cell hemoglobin concentr<strong>at</strong>ion, an elev<strong>at</strong>ed redcell distribution width, and reticulocytosis. On examin<strong>at</strong>ion <strong>of</strong> his peripheralsmear, the red blood cells exhibit a lack <strong>of</strong> central pallor and loss <strong>of</strong> the usualbiconcave shape, and the cells are fairly uniform in size and shape. Which <strong>of</strong>the following is true regarding this condition?‣ A It is usually transmitted as an autosomal recessive disorder and causes a membraneabnormality th<strong>at</strong> results in decreased osmotic fragility.‣ B Splenectomy can decrease the incidence <strong>of</strong> secondary complic<strong>at</strong>ions such as jaundice,pigmented gallstones, and anemia.‣ C <strong>Surgery</strong> should be delayed until after the age <strong>of</strong> 10 because <strong>of</strong> the risk foroverwhelming post-splenectomy sepsis in younger p<strong>at</strong>ients.‣ D It is less severe than other heredity membrane disorders, including pyruv<strong>at</strong>e kinasedeficiency, sickle cell anemia, thalassemia, and elliptocytosis, and less likely to requiresplenectomy than these conditions.‣ E It is associ<strong>at</strong>ed with a small spleen.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgHereditary spherocytosis (HS) is generally inherited as an autosomaldominant disease, although up to 25% <strong>of</strong> cases in the United St<strong>at</strong>es are inheritedin an autosomal recessive manner. It is the most common hereditary hemolyticdisorder in persons <strong>of</strong> northern European descent, with an incidence <strong>of</strong>approxim<strong>at</strong>ely 1 in 5000 or less. HS results from deficiency <strong>of</strong> an erythrocytecytoskeletal membrane protein, most commonly spectrin. Lack <strong>of</strong> spectrinproduces spherical erythrocytes th<strong>at</strong> are small and rigid with increased osmoticfragility and results in increased destruction <strong>of</strong> erythrocytes as they pass throughthe trabeculae <strong>of</strong> the spleen. The clinical manifest<strong>at</strong>ions are variable. Anemiamay develop, as well as jaundice, splenomegaly, and pigmented gallstones fromhemolysis. Splenectomy can decrease these secondary complic<strong>at</strong>ions butshould be delayed until after 6 years <strong>of</strong> age, if possible, to preserveimmunologic function in young children (who are <strong>at</strong> gre<strong>at</strong>est risk foroverwhelming post-splenectomy infection). Cholecystectomy may berequired in p<strong>at</strong>ients with symptom<strong>at</strong>ic cholelithiasis but otherwise mild HS.Splenectomy is clearly indic<strong>at</strong>ed for p<strong>at</strong>ients with severe anemia. The hereditarydisorders listed in choice D are <strong>of</strong>ten less severe than those in HS and much lesslikely to require splenectomy. Splenomegaly is a prominent fe<strong>at</strong>ure <strong>of</strong> HS.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgPartial vs total splenectomy in children withhereditary spherocytosis…‣ A is associ<strong>at</strong>ed with persistent anemia‣ B is associ<strong>at</strong>ed with a higher future risk <strong>of</strong> cholelithiasis‣ C is associ<strong>at</strong>ed with splenic regrowth th<strong>at</strong> predicts failure‣ D is associ<strong>at</strong>ed with a shorter postoper<strong>at</strong>ive length <strong>of</strong> stay‣ E will l<strong>at</strong>er require completion splenectomy


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.org


www.downst<strong>at</strong>esurgery.orgWhite Blood Cell<strong>Disorders</strong>


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgWh<strong>at</strong> is the most common primarysplenic neoplasm w/splenicinvolvement?‣ A) Hairy Cell Leukemia‣ B) Chronic Myelogenous Leukemia‣ C) Chronic Lymphocytic Leukemia‣ D) Hodgkin’s Lymphoma‣ E) Non-Hodgkin’s Lymphoma‣ F) Darned if I know!


www.downst<strong>at</strong>esurgery.orgHodgkin’s&Non-Hodgkin’sLymphoma


alone, most p<strong>at</strong>ients receive systemic chemotherapy.<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>A 23-year-old woman is seen with left supraclavicular adenop<strong>at</strong>hy. She hasno history <strong>of</strong> fever, chills, night swe<strong>at</strong>s, or weight loss. CT <strong>of</strong> the chest andabdomen shows no other findings. Bone marrow biopsy is neg<strong>at</strong>ive. Biopsy <strong>of</strong>the lymph node discloses nodular sclerosing Hodgkin's disease. Which <strong>of</strong> thefollowing st<strong>at</strong>ements regarding further surgical intervention for this p<strong>at</strong>ient isnot true?‣ A Staging laparotomy (or laparoscopy) for Hodgkin's disease, when indic<strong>at</strong>ed, includes thoroughabdominal explor<strong>at</strong>ion, splenectomy with splenic hilar lymphadenectomy, bil<strong>at</strong>eral wedge andcore needle liver biopsies, bil<strong>at</strong>eral retroperitoneal lymph node sampling, bone marrow biopsy,and oophoropexy for female p<strong>at</strong>ients.‣ B Staging laparotomy (or laparoscopy) has largely been supplanted by CT and positron emissiontomography (PET) for assessing the extent <strong>of</strong> disease.‣ C Eighty percent <strong>of</strong> p<strong>at</strong>ients undergoing splenectomy will have evidence <strong>of</strong> Hodgkin'sinvolvement <strong>of</strong> the spleen.www.downst<strong>at</strong>esurgery.org‣ D The spleen is the only site <strong>of</strong> intra-abdominal disease in approxim<strong>at</strong>ely one half <strong>of</strong> p<strong>at</strong>ients withHodgkin's disease found to have splenic involvement.‣ E Except for p<strong>at</strong>ients with early-stage Hodgkin disease, who may be tre<strong>at</strong>ed with radi<strong>at</strong>ion therapy


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgWhich <strong>of</strong> the following descriptions <strong>of</strong> the extent <strong>of</strong> Hodgkin'sdisease is paired with the correct clinical stage?‣ A Bil<strong>at</strong>eral involvement <strong>of</strong> the axillary lymph nodes with no subdiaphragm<strong>at</strong>ic diseaseis considered stage I.‣ B Epigastric lymph node and liver hilar lymph node involvement is stage III if there isno disease above the diaphragm.‣ C The presence <strong>of</strong> positive left cervical and right mediastinal nodes denotes stage IVdisease because <strong>of</strong> involvement <strong>of</strong> the contral<strong>at</strong>eral side.‣ D Splenic involvement in the presence <strong>of</strong> mediastinal lymph node involvementrepresents stage III disease.‣ E Bone marrow involvement represents stage II disease but carries a poor prognosis.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgLymphoma‣ Hodgkin’s‣ Malignant neoplasm‣ Lymphoreticular cell origin‣ Young adults 2 nd -3 rd decade‣ Tre<strong>at</strong>ment‣Chemotherapy & radi<strong>at</strong>ion‣ Splenectomy‣Thrombocytopenia‣Symptom<strong>at</strong>ic splenomegaly‣ Non-Hodgkin’s‣ Most common primarysplenic neoplasm w/splenicinvolvement‣ Splenectomy‣Anemia‣Massive splenomegaly‣Thrombocytopenia‣Neutropenia


alone, most p<strong>at</strong>ients receive systemic chemotherapy.<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>A 23-year-old woman is seen with left supraclavicular adenop<strong>at</strong>hy. She hasno history <strong>of</strong> fever, chills, night swe<strong>at</strong>s, or weight loss. CT <strong>of</strong> the chest andabdomen shows no other findings. Bone marrow biopsy is neg<strong>at</strong>ive. Biopsy <strong>of</strong>the lymph node discloses nodular sclerosing Hodgkin's disease. Which <strong>of</strong> thefollowing st<strong>at</strong>ements regarding further surgical intervention for this p<strong>at</strong>ient isnot true?‣ A Staging laparotomy (or laparoscopy) for Hodgkin's disease, when indic<strong>at</strong>ed, includes thoroughabdominal explor<strong>at</strong>ion, splenectomy with splenic hilar lymphadenectomy, bil<strong>at</strong>eral wedge andcore needle liver biopsies, bil<strong>at</strong>eral retroperitoneal lymph node sampling, bone marrow biopsy,and oophoropexy for female p<strong>at</strong>ients.‣ B Staging laparotomy (or laparoscopy) has largely been supplanted by CT and positron emissiontomography (PET) for assessing the extent <strong>of</strong> disease.‣ C Eighty percent <strong>of</strong> p<strong>at</strong>ients undergoing splenectomy will have evidence <strong>of</strong> Hodgkin'sinvolvement <strong>of</strong> the spleen.www.downst<strong>at</strong>esurgery.org‣ D The spleen is the only site <strong>of</strong> intra-abdominal disease in approxim<strong>at</strong>ely one half <strong>of</strong> p<strong>at</strong>ients withHodgkin's disease found to have splenic involvement.‣ E Except for p<strong>at</strong>ients with early-stage Hodgkin disease, who may be tre<strong>at</strong>ed with radi<strong>at</strong>ion therapy


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgStaging laparotomy (or laparoscopy) for Hodgkinlymphoma is now largely <strong>of</strong> historical interest because PET andCT have all but replaced the need for oper<strong>at</strong>ive staging. Thecomponents <strong>of</strong> a staging laparotomy (laparoscopy) are listed inchoice A. When splenectomy is performed, approxim<strong>at</strong>ely 40%<strong>of</strong> p<strong>at</strong>ients will be found to have splenic involvement. In onehalf <strong>of</strong> these p<strong>at</strong>ients with splenic involvement, there will be noother site <strong>of</strong> disease in the abdominal cavity or pelvis.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgWhich <strong>of</strong> the following descriptions <strong>of</strong> the extent <strong>of</strong> Hodgkin'sdisease is paired with the correct clinical stage?‣ A Bil<strong>at</strong>eral involvement <strong>of</strong> the axillary lymph nodes with no subdiaphragm<strong>at</strong>ic diseaseis considered stage I.‣ B Epigastric lymph node and liver hilar lymph node involvement is stage III if there isno disease above the diaphragm.‣ C The presence <strong>of</strong> positive left cervical and right mediastinal nodes denotes stage IVdisease because <strong>of</strong> involvement <strong>of</strong> the contral<strong>at</strong>eral side.‣ D Splenic involvement in the presence <strong>of</strong> mediastinal lymph node involvementrepresents stage III disease.‣ E Bone marrow involvement represents stage II disease but carries a poor prognosis.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgAccording to the Ann Arbor classific<strong>at</strong>ion, Hodgkin'sdisease is staged as follows: stage I—one or two contiguousareas <strong>of</strong> lymph node involvement on the same side <strong>of</strong> thediaphragm; stage II—two noncontiguous areas on the same side<strong>of</strong> the diaphragm; stage III—involvement <strong>of</strong> lymph node groupson both sides <strong>of</strong> the diaphragm (the spleen is considered a lymphnode for this classific<strong>at</strong>ion); and stage IV—involvement <strong>of</strong> theliver, bone marrow, lungs, or any other non–lymph node tissue,exclusive <strong>of</strong> the spleen. A superscript E signifies extranodalinvolvement adjacent to the involved lymph nodes. In addition,p<strong>at</strong>ients are subc<strong>at</strong>egorized as being asymptom<strong>at</strong>ic (A) or havingconstitutional symptoms (B) if they have had fever (>38 C),night swe<strong>at</strong>s, or 10% weight loss within 6 months.


www.downst<strong>at</strong>esurgery.orgHairy CellLeukemia (HCL)


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgHairy cell leukemia is diagnosed in a 58-year-old man with pancytopeniaand palpable splenomegaly. He is referred to your <strong>of</strong>fice for a second opinionafter another surgeon did not <strong>of</strong>fer him a splenectomy. Which <strong>of</strong> the followingis true regarding his condition?‣ A It is a B-cell lymphoma characterized by cytoplasmic protrusions th<strong>at</strong> first invade thethymus and then the spleen secondarily.‣ B The mainstay <strong>of</strong> tre<strong>at</strong>ment is methotrex<strong>at</strong>e chemotherapy.‣ C It is associ<strong>at</strong>ed with a two- to threefold risk for the development <strong>of</strong> a secondmalignancy, including prost<strong>at</strong>e, skin, and lung cancers.‣ D Splenectomy may be palli<strong>at</strong>ive but is infrequently done because <strong>of</strong> the lack <strong>of</strong>sustained response.‣ E The 5-year survival r<strong>at</strong>e is less than 20%.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgPhysiology & Present<strong>at</strong>ion <strong>of</strong> HCL‣ B-lymphocytes w/cytoplasmic projections from cell membrane‣ 5 th decade <strong>of</strong> life‣ Symptoms‣ Splenomegaly‣ Pancytopenia‣ 2ry hypersplenism & replacement <strong>of</strong> bone marrow by leukemiccells‣ Neoplastic mononuclear cells in periphery & bone marrow


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgManagement <strong>of</strong> HCL‣ Medical‣ Pentost<strong>at</strong>in‣ Cladribine‣ 92% response r<strong>at</strong>e‣ Complete remission‣80%‣ 10 yr survival‣ Splenectomy‣ Rarely indic<strong>at</strong>ed‣ Indic<strong>at</strong>ions:‣Pancytopenia refractory tomedical therapy‣Splenic rupture‣Severe bleeding fromthrombocytopenia‣>90%


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgHairy cell leukemia is diagnosed in a 58-year-old man with pancytopeniaand palpable splenomegaly. He is referred to your <strong>of</strong>fice for a second opinionafter another surgeon did not <strong>of</strong>fer him a splenectomy. Which <strong>of</strong> the followingis true regarding his condition?‣ A It is a B-cell lymphoma characterized by cytoplasmic protrusions th<strong>at</strong> first invade thethymus and then the spleen secondarily.‣ B The mainstay <strong>of</strong> tre<strong>at</strong>ment is methotrex<strong>at</strong>e chemotherapy.‣ C It is associ<strong>at</strong>ed with a two- to threefold risk for the development <strong>of</strong> a secondmalignancy, including prost<strong>at</strong>e, skin, and lung cancers.‣ D Splenectomy may be palli<strong>at</strong>ive but is infrequently done because <strong>of</strong> the lack <strong>of</strong>sustained response.‣ E The 5-year survival r<strong>at</strong>e is less than 20%.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgHairy cell leukemia is a clonal disorder <strong>of</strong> B lymphocytesth<strong>at</strong> involve the blood and bone marrow (not the thymus). Itusually affects elderly men and is characterized by filamentouscytoplasmic projections on lymphocytes and splenomegaly.Pancytopenia is common because <strong>of</strong> bone marrow replacementby leukemic cells. It is associ<strong>at</strong>ed with a two- to threefold risk fora second solid tumor, most commonly prost<strong>at</strong>e, skin, lung, orgastrointestinal tract adenocarcinoma. As many as 10% <strong>of</strong>affected p<strong>at</strong>ients have an indolent course requiring no specifictherapy. Survival after medical tre<strong>at</strong>ment with purine analogues(cladribine) is generally good (80% <strong>at</strong> 5 years). Splenectomy isnow reserved for p<strong>at</strong>ients who fail medical management or havebleeding complic<strong>at</strong>ions from thrombocytopenia. Splenectomyresults in improvement <strong>of</strong> the pancytopenia in 40% or more <strong>of</strong>p<strong>at</strong>ients and may be sustained for many years.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgOther White Blood Cell <strong>Disorders</strong>‣ Chronic LymphocyticLeukemia‣ B-cell leukemia‣ Progressive accumul<strong>at</strong>ion <strong>of</strong>functionally incompetentlymphocytes‣ Splenectomy:‣Sx <strong>of</strong> Massive splenomegaly‣Severe thrombocytopenia &‣ Chronic MyelogenousLeukemia‣ Abnormal prolifer<strong>at</strong>ion &accumul<strong>at</strong>ion <strong>of</strong>granulocytes‣ Philadelphia chromosome‣ Tre<strong>at</strong>ment: Im<strong>at</strong>inib‣ Bone marrow transplant‣ Splenectomy for palli<strong>at</strong>ion


www.downst<strong>at</strong>esurgery.orgGenetic Deficiencies


www.downst<strong>at</strong>esurgery.orgThalassemmia


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgThalassemia‣ Defect in synthesis <strong>of</strong> hemoglobin chains: AD‣ Inadequ<strong>at</strong>e hemoglobin production‣ Minor – microcytosis & mild anemia‣ Major – severe‣ Symptoms‣ Abdominal swelling & pallor‣ Growth retard<strong>at</strong>ion & skeletal abnormalities‣ Irritability‣ Jaundice & pigmented gallstones‣ Splenomegaly


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgManagement <strong>of</strong> Thalassemia‣ Medical‣ Lifelong bloodtransfusion‣ Iron chel<strong>at</strong>ion therapy‣ Splenectomy‣ Severe splenomegaly‣ Transfusion requirement>180-200 mL/kg/yr‣ Reduces transfusion by 25-Bone Marrow Transplantis only cure60%‣ May developthrombocytosis


www.downst<strong>at</strong>esurgery.orgSickle Cell Anemia


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgCharacteristics <strong>of</strong> Sickle Cell‣ Amino acid substitution on β chain <strong>of</strong> hemoglobin‣ HgS deforms & sickle in low-oxygen tension‣ Stasis & vasoocclusion in microvascul<strong>at</strong>ure‣ Tissue ischemia, severe pain, & chronic organ tissue damage‣ Autosplenectomy from multiple infarcts‣ Indic<strong>at</strong>ions for Splenectomy‣ Splenic abscess & sequestr<strong>at</strong>ion


www.downst<strong>at</strong>esurgery.orgGaucher Disease


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>Present<strong>at</strong>ion <strong>of</strong> Gaucher Disease‣ Deficiency <strong>of</strong> glucocerebrosidase: AR‣ Deposition in reticuloendothelia system‣ Organomegaly, pulmonary infiltr<strong>at</strong>es, bone marrow infiltr<strong>at</strong>es‣ Symptoms:www.downst<strong>at</strong>esurgery.org‣ Bone pain‣ anemia & thrombocytopenia‣ Osteopenia‣ Osteonecrosis‣ Massive hep<strong>at</strong>osplenomegaly


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>‣ Partial splenectomywww.downst<strong>at</strong>esurgery.orgTre<strong>at</strong>ment <strong>of</strong> Gaucher‣ Preserve splenic function‣ Thrombocytopenia improves‣ Side Effects:‣ Severe bone disease‣ Osteonecrosis‣ Worsening lung or kidney function


www.downst<strong>at</strong>esurgery.orgPyruv<strong>at</strong>e KinaseDeficiency(PKD)


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>Present<strong>at</strong>ion <strong>of</strong> PKD‣ Most common genetic defect causing congenitalenzymop<strong>at</strong>hic hemolytic anemia‣ Defect in glycolytic pahtway‣ Deficiency <strong>of</strong> ATP‣ RBC’s less deformable & destroyed by spleen‣ Splenomegalywww.downst<strong>at</strong>esurgery.org‣ Splenectomy in severe hemolytic anemia or frequenttransfusions


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgOther Genetic Deficiencies‣ G6PD Deficiency‣ Most common enzyme defectin hereditary hemolyticanemia‣ X-linked‣ Damage <strong>of</strong> RBC by toxic O2products‣Acute infections, oxidant drugs(sulfa & antimalarials), favabeans‣ Amyloidosis‣ Extracellular deposition <strong>of</strong>insoluble fibrillar proteins intissues & organs‣ Hep<strong>at</strong>osplenomegaly 25%‣ Severe splenomegaly 10%‣ Functional hyposplenism &splenectomy


www.downst<strong>at</strong>esurgery.orgMyeloprolifer<strong>at</strong>ive<strong>Disorders</strong>


www.downst<strong>at</strong>esurgery.orgPrimaryMyel<strong>of</strong>ibrosis(PMF)


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>‣ 65 yowww.downst<strong>at</strong>esurgery.orgPresent<strong>at</strong>ion <strong>of</strong> PMF‣ Chronic, malignant hem<strong>at</strong>ologic disorder‣ Hyperplasia <strong>of</strong> abnormal myeloid precursor cells‣ Marrow fibrosis‣ Extramedullary hem<strong>at</strong>opoiesis in liver & spleen‣ Symptoms‣ Splenomegaly‣ Cytopenias – splenic sequestr<strong>at</strong>ion‣ Portal hypertension – venous thrombosis‣ Men > Women


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgIndic<strong>at</strong>ions for Splenectomy in PMF‣ Thrombocytopenia‣ Hemolysis requiring significant transfusions‣ Pain from massive splenomegaly‣ Recurrent splenic infarctions‣ Portal hypertension w/refractory ascites & varicealhemorrhage‣ Morbidity (15-30%) & mortality (10%)‣ Hemorrhage, infection, leukocytosis, severe thrombocytosis, progressivehep<strong>at</strong>omegaly, f<strong>at</strong>al hep<strong>at</strong>ic failure, & leukemic transform<strong>at</strong>ion


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgOther Bone Marrow <strong>Disorders</strong>‣ CML‣ Polycythemia vera‣ Essential thrombocytopenia‣ Hypereosinophilicsyndromes‣ Mast cell disease‣ Splenectomy:‣ Palli<strong>at</strong>ive role‣ Massive splenomegaly‣ Cytopenia‣ Chronic neutrophilicleukemia


www.downst<strong>at</strong>esurgery.orgOper<strong>at</strong>iveConsider<strong>at</strong>ions


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgWhich <strong>of</strong> the following is anabsolute contraindic<strong>at</strong>ion forlaparoscopic splenectomy?‣ A) Massive splenomegaly‣ B) Portal hypertension‣ C) Malignancy‣ D) Morbid obesity (BMI>35)‣ E) Pl<strong>at</strong>elet count


www.downst<strong>at</strong>esurgery.orgLaparoscopicvsOpen Splenectomy


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgAfter failing medical therapy, a 46-year-old woman with ITP is referred toyou for splenectomy. She is very interested in a laparoscopic procedure andwas told by her hem<strong>at</strong>ologist th<strong>at</strong> she is a good candid<strong>at</strong>e. Review <strong>of</strong> her CTscan shows a normal-sized spleen and normal splenic vascular an<strong>at</strong>omy. Which<strong>of</strong> the following is true about laparoscopic splenectomy?‣ A Oper<strong>at</strong>ive mortality r<strong>at</strong>es are the same regardless <strong>of</strong> the underlying disease type.‣ B Laparoscopic splenectomy has similar success r<strong>at</strong>es as open splenectomy, exceptwhen performed for ITP.‣ C The r<strong>at</strong>e <strong>of</strong> conversion from laparoscopic to open splenectomy is 0% to 20%.‣ D Laparoscopic splenectomy can be considered for spleen sizes up to 35 cm.‣ E Laparoscopic splenectomy results in a higher incidence <strong>of</strong> splenosis than does theopen approach.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgPre-Op Evalu<strong>at</strong>ion‣ CT imaging‣ Splenic size‣ An<strong>at</strong>omic rel<strong>at</strong>ionship w/surrounding organs‣ An<strong>at</strong>omy <strong>of</strong> variable splenic blood supply‣ Loc<strong>at</strong>e accessory spleens‣ Pre-op splenic arterial emboliz<strong>at</strong>ion‣ Massive splenomegaly‣ Portal hypertension


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.org‣ Blood productsPre-Op Consider<strong>at</strong>ions‣ Especially in thrombocytopenia‣ Transfuse only for bleeding after splenic artery lig<strong>at</strong>ion‣ Pre-op antibiotics 60 minutes prior‣ NG/OG tube‣ Stress-dose steroids if chronic use‣ Vaccin<strong>at</strong>ions 2 wks prior‣ Haemophilius inflenzae B‣ Polyvalent Pneumococcus‣ Meningococcus


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgSplenectomy‣ Open‣ Midline vs left subcostal‣ Enter lesser sac‣ Laparoscopic‣ Abdominal vs right l<strong>at</strong>eral decub‣ Mobilize splenic flexure‣ Dissect vessels <strong>at</strong> hilum‣ Lig<strong>at</strong>e splenic hilum 1 st‣Facilit<strong>at</strong>es plt transfusion in ITP‣Vascular stapler or suture lig<strong>at</strong>e‣ Divide splenogastric ligament‣Lig<strong>at</strong>e short gastrics‣ Splenic pedicle dissected fromlower pole‣ Lig<strong>at</strong>e vascular pedicle & shortgastrics‣ Macer<strong>at</strong>e spleen in specimenbag


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.org‣ Spleen sizeLaparoscopic Splenectomy‣ Normal: 11 cm & 100-250g‣ Splenomegaly: >15cm‣ Massive Splenomegaly: >20cm‣ Megspleen: >22cm‣ Higher r<strong>at</strong>e <strong>of</strong> conversion rel<strong>at</strong>ed to increasing size‣ Contraindic<strong>at</strong>ions:‣ Portal hypertension from cirrhosis


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgAfter failing medical therapy, a 46-year-old woman with ITP is referred toyou for splenectomy. She is very interested in a laparoscopic procedure andwas told by her hem<strong>at</strong>ologist th<strong>at</strong> she is a good candid<strong>at</strong>e. Review <strong>of</strong> her CTscan shows a normal-sized spleen and normal splenic vascular an<strong>at</strong>omy. Which<strong>of</strong> the following is true about laparoscopic splenectomy?‣ A Oper<strong>at</strong>ive mortality r<strong>at</strong>es are the same regardless <strong>of</strong> the underlying disease type.‣ B Laparoscopic splenectomy has similar success r<strong>at</strong>es as open splenectomy, exceptwhen performed for ITP.‣ C The r<strong>at</strong>e <strong>of</strong> conversion from laparoscopic to open splenectomy is 0% to 20%.‣ D Laparoscopic splenectomy can be considered for spleen sizes up to 35 cm.‣ E Laparoscopic splenectomy results in a higher incidence <strong>of</strong> splenosis than does theopen approach.


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgLaparoscopic splenectomy is increasingly being selected as the techniquewhen elective splenectomy is indic<strong>at</strong>ed. The oper<strong>at</strong>ive morbidity and mortalityr<strong>at</strong>es after splenectomy are higher for p<strong>at</strong>ients with malignant hem<strong>at</strong>ologicdisease than for those with benign disease. The risk for postoper<strong>at</strong>ive portalvenous thrombosis is gre<strong>at</strong>est for p<strong>at</strong>ients with myeloprolifer<strong>at</strong>ive disorders.For idiop<strong>at</strong>hic thrombocytopenic purpura, laparoscopic splenectomy hassuccess r<strong>at</strong>es similar to those <strong>of</strong> open splenectomy. Regardless <strong>of</strong> the surgicalapproach, when splenectomy is performed for hem<strong>at</strong>ologic disease, a carefulsearch for accessory spleens must be performed. Their appearance may mimicth<strong>at</strong> <strong>of</strong> a lymph node, and they may more easily be palp<strong>at</strong>ed than visualized,thus giving rise to concern th<strong>at</strong> the laparoscopic approach may overlook someaccessory spleens. The conversion r<strong>at</strong>e to an open procedure is reported torange from 0% to 20%. Conversion is usually secondary to bleeding, butextensive adhesions, obesity, and splenomegaly may also be factors. Spleensup to 20 to 25 cm in size are amenable to laparoscopic splenectomy. A splenicsize <strong>of</strong> 35 cm is generally too large for a laparoscopic approach. Thelaparoscopic approach does not result in a higher incidence <strong>of</strong> splenosis(autotransplant<strong>at</strong>ion and subsequent growth <strong>of</strong> splenic fragments from aninjured spleen th<strong>at</strong> may remain functional and occasionally cause pain orsymptoms rel<strong>at</strong>ed to a mass effect).


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgSix months after laparoscopic splenectomyfor ITP, a 38 yo woman with lupus remainsthrombocytopenic (plt 42,000/mm3). Thenext step should be…‣ A) Pl<strong>at</strong>elet transfusion‣ B) Evalu<strong>at</strong>ion for accesory spleen‣ C) Plasmapharesis‣ D) Bone marrow biopsy‣ E) Aspirin‣ F) I give up!!!


www.downst<strong>at</strong>esurgery.orgIn Conclusion….


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgPrimary therapy for a 5 yo girl w/new-onsetpetechiae & ecchymosis, pl<strong>at</strong>elet count45,000/mm3, and normal-size spleen…‣ A) Corticosteroids‣ B) Splenectomy‣ C) Plasmapharesis‣ D) Chemotherapy‣ E) Enzyme Replacement‣ F) None <strong>of</strong> the Above


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>Primary therapy for a 56 yo manw/pancytopenia, blood smear showingcircul<strong>at</strong>ing cells with cytoplasmicprotrusions, & splenomegaly…‣ A) Corticosteroids‣ B) Splenectomy‣ C) Plasmapharesis‣ D) Chemotherapy‣ E) Enzyme Replacement‣ F) None <strong>of</strong> the Abovewww.downst<strong>at</strong>esurgery.org


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>Primary therapy for a 35 yo man w/mentalst<strong>at</strong>us changes, hemoglobin <strong>of</strong> 7 g/dL,fever, renal failure, pl<strong>at</strong>elet count <strong>of</strong>40,000/mm3 and splenomegaly…‣ A) Corticosteroids‣ B) Splenectomy‣ C) Plasmapharesis‣ D) Chemotherapy‣ E) Enzyme Replacement‣ F) None <strong>of</strong> the Abovewww.downst<strong>at</strong>esurgery.org


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>Primary therapy for a 10 yo girlw/recurring episodes <strong>of</strong> severe anemia withjaundice, red cells with osmotic fragility &normal-size spleen…‣ A) Corticosteroids‣ B) Splenectomy‣ C) Plasmapharesis‣ D) Chemotherapy‣ E) Enzyme Replacement‣ F) None <strong>of</strong> the Abovewww.downst<strong>at</strong>esurgery.org


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong>www.downst<strong>at</strong>esurgery.orgPrimary therapy for a 21 yo woman w/skindiscolor<strong>at</strong>ion, f<strong>at</strong>igue, andhep<strong>at</strong>osplenomegaly…‣ A) Corticosteroids‣ B) Splenectomy‣ C) Plasmapharesis‣ D) Chemotherapy‣ E) Enzyme Replacement‣ F) None <strong>of</strong> the Above


www.downst<strong>at</strong>esurgery.org


<strong>Hem<strong>at</strong>ologic</strong> <strong>Disorders</strong> www.downst<strong>at</strong>esurgery.orgReferences• Cameron JL. Current Surgical Therapy, 10 th ed. 2010.• Moake JL. Von Willebrand Factor, ADAMTS-13, and Thrombotic Thrombocytopenic Purpura. Semin inHem<strong>at</strong>ol. 2004; 41(1)• Townsend CM. Sabiston Textbook <strong>of</strong> <strong>Surgery</strong>, 18 th ed. 2007.• Velasco, JM. Rush University Medical Center Review <strong>of</strong> <strong>Surgery</strong>, 5 th Edition. 2011.• Weigelt, JA. SESAP 14. American College <strong>of</strong> Surgeons, 2010.


www.downst<strong>at</strong>esurgery.org

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!